Search
Black Diamond Therapeutics Inc
BDTXAdd to Watchlist
2.010USD
+0.170+9.24%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
114.46MMarket Cap
LossP/E TTM
Black Diamond Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Black Diamond Therapeutics Inc is 6.66, ranking 306 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.64, which is -1277.42% below the recent high of 31.04 and -79.11% above the recent low of -4.72.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.